Surplus Ceramides: An Added Twist in the Tale of TREM2 and Insulin Resistance

Diabetes. 2021 Sep;70(9):1926-1928. doi: 10.2337/dbi21-0017. Epub 2021 Aug 20.

Authors

Kierstin L Webster¹, Lev Becker^{2

3}

Affiliations

¹ Committee on Molecular Metabolism and Nutrition, The University of Chicago, Chicago, IL.
² Committee on Molecular Metabolism and Nutrition, The University of Chicago, Chicago, IL levb@uchicago.edu.
³ Ben May Department for Cancer Research, The University of Chicago, Chicago, IL.

No abstract available

Publication types

Comment

MeSH terms

Ceramides
Humans
Insulin Resistance*
Membrane Glycoproteins
Receptors, Immunologic

Substances

Ceramides
Membrane Glycoproteins
Receptors, Immunologic
TREM2 protein, human

Grants and funding

R01 DK102960/DK/NIDDK NIH HHS/United States